Cytosorbents Corp Share Price OTC Bulletin Board
Equities
CTSO
US23283X1072
Advanced Medical Equipment & Technology
Sales 2024 * | 39.52M 3.1B | Sales 2025 * | 46.83M 3.67B | Capitalization | 48.88M 3.83B |
---|---|---|---|---|---|
Net income 2024 * | -20M -1.57B | Net income 2025 * | -9M -706M | EV / Sales 2024 * | 1.24 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.04 x |
P/E ratio 2024 * |
-2.35
x | P/E ratio 2025 * |
-4.79
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.8% |
Latest transcript on Cytosorbents Corp
Managers | Title | Age | Since |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 23/07/08 |
Vincent Capponi
PSD | President | 66 | 24/04/02 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 13/07/15 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 23/07/08 |
Edward Jones
BRD | Director/Board Member | 75 | 31/03/07 |
1st Jan change | Capi. | |
---|---|---|
+7.87% | 223B | |
+11.83% | 195B | |
+18.87% | 144B | |
+30.03% | 111B | |
+2.32% | 65.19B | |
+14.15% | 53.02B | |
+2.68% | 50.28B | |
+6.60% | 44.15B | |
+1.85% | 36.45B |